BBC3 and glioblastoma: To gather further insight into this mechanism, we also evaluated the response of iPA treatment in normal human astrocyte (NHA) primary cells and, in an additional glioblastoma cell line, U251MG, harboring a mutated p 53 (R273H) that lacks the DNA-binding activity and is therefore incapable of activating target genes, including PUMA [32].